GI Innovation, Inc. (358570.KQ)

KRW 9790.0

(-4.39%)

Gross Profit Summary of GI Innovation, Inc.

  • GI Innovation, Inc.'s latest annual gross profit in 2023 was 1.98 Billion KRW , up 479.96% from previous year.
  • GI Innovation, Inc.'s latest quarterly gross profit in 2024 Q2 was -779.08 Million KRW , down -2.09% from previous quarter.
  • GI Innovation, Inc. reported a annual gross profit of 343.02 Million KRW in annual gross profit 2022, down -90.07% from previous year.
  • GI Innovation, Inc. reported a annual gross profit of 3.45 Billion KRW in annual gross profit 2021, down -64.9% from previous year.
  • GI Innovation, Inc. reported a quarterly gross profit of -763.12 Million KRW for 2024 Q1, down -119.38% from previous quarter.
  • GI Innovation, Inc. reported a quarterly gross profit of 3.93 Billion KRW for 2023 Q4, up 591.44% from previous quarter.

Annual Gross Profit Chart of GI Innovation, Inc. (2023 - 2019)

Historical Annual Gross Profit of GI Innovation, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 1.98 Billion KRW 479.96%
2022 343.02 Million KRW -90.07%
2021 3.45 Billion KRW -64.9%
2020 9.83 Billion KRW 252.69%
2019 2.78 Billion KRW 0.0%

Peer Gross Profit Comparison of GI Innovation, Inc.

Name Gross Profit Gross Profit Difference
HLB Co., Ltd. -6.01 Billion KRW 133.088%
iNtRON Biotechnology, Inc. 4.56 Billion KRW 56.381%
BINEX Co., Ltd. 56.65 Billion KRW 96.489%
Bioneer Corporation 199.25 Billion KRW 99.002%
Anterogen.Co.,Ltd. 2.21 Billion KRW 10.121%
MEDIPOST Co., Ltd. 40.18 Billion KRW 95.049%
CrystalGenomics, Inc. 1.45 Billion KRW -36.542%
Helixmith Co., Ltd 2.12 Billion KRW 6.241%
Chabiotech Co.,Ltd. 255.19 Billion KRW 99.22%
Medy-Tox Inc. 128.16 Billion KRW 98.448%
Peptron, Inc. 1.14 Billion KRW -74.422%
Amicogen, Inc. 51.51 Billion KRW 96.138%
Genexine, Inc. 387.48 Million KRW -413.42%
HLB Therapeutics Co.,Ltd. 6.69 Billion KRW 70.282%
LegoChem Biosciences, Inc. 17.79 Billion KRW 88.822%
ALTEOGEN Inc. 31.19 Billion KRW 93.623%
PharmaResearch Co., Ltd. 182.25 Billion KRW 98.908%
SillaJen, Inc. 1.45 Billion KRW -36.567%
JETEMA, Co., Ltd. 26.58 Billion KRW 92.516%
OliX Pharmaceuticals,Inc 14.42 Billion KRW 86.206%
Genomictree Inc. -1.03 Billion KRW 291.55%
MedPacto, Inc. -1.83 Billion KRW 208.554%
D&D Pharmatech 18.67 Billion KRW 89.348%
EASY BIO,Inc. 50.88 Billion KRW 96.09%